MANUFACTURERS LIFE INSURANCE COMPANY, THE - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$99,000
+106.2%
50,289
+30.9%
0.00%
Q4 2020$48,000
-11.1%
38,411
+28.3%
0.00%
Q3 2020$54,000
-82.4%
29,947
-22.9%
0.00%
Q2 2020$307,000
+45.5%
38,860
-3.5%
0.00%
Q1 2020$211,000
+8.2%
40,288
+12.8%
0.00%
Q4 2019$195,000
+4.3%
35,728
-4.4%
0.00%
Q3 2019$187,000
-27.8%
37,3890.0%0.00%
Q2 2019$259,000
+4.4%
37,389
+4.8%
0.00%
Q1 2019$248,000
+29.2%
35,681
+8.2%
0.00%
Q4 2018$192,000
-26.7%
32,964
-5.2%
0.00%
Q3 2018$262,000
+24.8%
34,762
-16.3%
0.00%
Q2 2018$210,000
-12.1%
41,537
+6.4%
0.00%
Q1 2018$239,000
-11.5%
39,053
+2.5%
0.00%
Q4 2017$270,000
+7.6%
38,103
+8.6%
0.00%
Q3 2017$251,000
+10.1%
35,086
-3.0%
0.00%
Q2 2017$228,000
+1241.2%
36,181
+1347.2%
0.00%
Q3 2016$17,0002,5000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2020
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders